Veterinary Intravenous (IV) Solutions Market Forecast: How Big Will It Be by 2030?
Uncover key drivers, emerging technologies, and competitive movements shaping the implantable brain-computer interfaces market from 2026–2035 with trusted insights from The Business Research Company
How is the Veterinary Intravenous (IV) Solutions Market size predicted to change over the forecast window of 2026–2035?
The veterinary intravenous (iv) solutions market has seen significant expansion in recent years. It is anticipated to increase from $1.62 billion in 2025 to $1.75 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.1%. The historical expansion of this market can be attributed to the rising prevalence of dehydration and electrolyte imbalances in animals, growth in the companion animal population, an increasing number of veterinary hospitals and clinics, the adoption of conventional iv solutions, and technological advancements in veterinary fluid therapy.
The veterinary intravenous (iv) solutions market size is anticipated to experience robust growth in the upcoming years, projected to reach $2.36 billion in 2030, at a compound annual growth rate (CAGR) of 7.7%. This expansion during the forecast period is attributed to the growing demand for advanced isotonic and colloid solutions, the increasing adoption of parenteral nutrition in veterinary care, the development of specialized iv solutions for critical care, rising awareness of fluid therapy benefits, and the expansion of veterinary emergency and critical care services. Major trends influencing this period include the development of advanced isotonic and balanced electrolyte solutions, increased use of synthetic and natural colloids, growth in parenteral nutrition solutions for companion and production animals, the adoption of pre-mixed and ready-to-use iv solutions, and the broadening of veterinary critical care and emergency fluid therapy.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20686&type=smp
Which Drivers Are Contributing To The Expansion Of The Veterinary Intravenous (IV) Solutions Market?
The rising investment in animal health products is anticipated to boost the expansion of the veterinary intravenous (IV) solutions market in the coming years. These products encompass various medications, supplements, and treatments aimed at preserving or enhancing the well-being and health of animals. Factors contributing to this increased expenditure on animal health products include a rise in pet ownership, greater awareness of animal welfare, progress in veterinary care, and the necessity for improved disease prevention and treatment methods. Veterinary IV solutions play a role in this increased spending on animal health products by addressing immediate medical requirements and advancing veterinary treatment. For instance, in March 2024, according to the Republic of Estonia Agency of Medicines, an Estonia-based regulatory authority, in 2023, the veterinary medicinal products market increased by 6.9%, reaching $20.54 million (18.6 million euros) up from USD 19.21 million (17.40 million euros) in 2022. Consequently, the growing expenditure on animal health products is fueling the growth of the veterinary intravenous (IV) solutions market.
What Segment Classifications Make Up The Veterinary Intravenous (IV) Solutions Market?
The veterinary intravenous (iv) solutions market covered in this report is segmented –
1) By Product: Isotonic Crystalloids, Dextrose Solutions, Synthetic Colloids, Natural Colloids, Parenteral Nutrition
2) By Animal Type: Companion Animals, Production Animals
3) By End-User: Veterinary Hospitals And Clinics, Research Institutes, Other End-Users
Subsegments:
1) By Isotonic Crystalloids: Normal Saline (0.9% NaCl), Lactated Ringer’s Solution, Dextrose In Water (D5W), Ringer’s Solution, Balanced Electrolyte Solutions
2) By Dextrose Solutions: Dextrose 5% In Water (D5W), Dextrose 10% In Water (D10W), Dextrose 20% In Water (D20W), Dextrose 50% In Water (D50W)
3) By Synthetic Colloids: Hydroxyethyl Starch (HES), Dextran, Gelatins
4) By Natural Colloids: Albumin, Fresh Frozen Plasma (FFP), Blood Products
5) By Parenteral Nutrition: Total Parenteral Nutrition (TPN) Solutions, Partial Parenteral Nutrition Solutions, Lipid Emulsions, Amino Acid Solutions
Which Trends Are Influencing The Performance And Direction Of The Veterinary Intravenous (IV) Solutions Market?
Leading companies in the veterinary intravenous (IV) solutions market are concentrating on developing advanced products, such as fluoroquinolone, to enhance their efficacy and safety profiles. Fluoroquinolones are potent antibiotics used in both human and veterinary medicine to treat various bacterial infections, which require careful management to minimize the risk of resistance and side effects. For example, in April 2024, Elanco, a US-based pharmaceutical company, introduced Pradalex, a pradofloxacin injection solution approved by the US Food and Drug Administration (FDA), a US health organization. This approval for swine is for addressing swine respiratory disease (SRD) associated with bordetella bronchiseptica, Glaesserella (Haemophilus) parasuis, Pasteurella multocida, streptococcus suis, and mycoplasma hyopneumoniae. Pradalex is categorized as a 3rd generation fluoroquinolone and is deemed a critically important antimicrobial. The drug’s label states that its use should only occur after other non-fluoroquinolone therapeutic options have been considered.
Which Major Firms Are Strengthening Their Position In The Veterinary Intravenous (IV) Solutions Market?
Major companies operating in the veterinary intravenous (iv) solutions market are Merck & Co. Inc., Baxter International Inc., Zoetis Inc., Fresenius Kabi AG, Elanco Animal Health Incorporated, B. Braun Melsungen AG, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol SA, Norbrook Laboratories Limited, Ceva Santé Animale, Revival Animal Health Inc., Aromor Animal Health, Jorgensen Laboratories LLC, Pharmacosmos AS, Sykes Veterinary International Pty Ltd., Rusoma Laboratories Private Limited, Patterson Companies Inc., NexGen Veterinary, Soxa Formulations & Research Pvt. Ltd
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The Veterinary Intravenous (IV) Solutions Market?
North America was the largest region in the veterinary intravenous (IV) solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary intravenous (iv) solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Veterinary Intravenous (IV) Solutions Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20686&type=smp
Browse Through More Reports Similar to the Global Veterinary Intravenous (IV) Solutions Market 2026, By The Business Research Company
Veterinary Hematology Analyzers Global Market Report 2026
Veterinary Telehealth Market 2026
https://www.thebusinessresearchcompany.com/report/veterinary-telehealth-market
Veterinary Stereotactic Radiosurgery System Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
